nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Thrombosis—Carmustine—malignant glioma	0.026	0.0335	CcSEcCtD
Dicyclomine—Necrosis—Carmustine—malignant glioma	0.0235	0.0302	CcSEcCtD
Dicyclomine—Speech disorder—Carmustine—malignant glioma	0.0214	0.0276	CcSEcCtD
Dicyclomine—Speech disorder—Temozolomide—malignant glioma	0.0207	0.0266	CcSEcCtD
Dicyclomine—Injection site reaction—Carmustine—malignant glioma	0.0183	0.0236	CcSEcCtD
Dicyclomine—Thrombophlebitis—Carmustine—malignant glioma	0.0154	0.0199	CcSEcCtD
Dicyclomine—Thrombophlebitis—Temozolomide—malignant glioma	0.0149	0.0192	CcSEcCtD
Dicyclomine—Amnesia—Carmustine—malignant glioma	0.0142	0.0183	CcSEcCtD
Dicyclomine—Nasal congestion—Temozolomide—malignant glioma	0.0142	0.0183	CcSEcCtD
Dicyclomine—Amnesia—Temozolomide—malignant glioma	0.0137	0.0177	CcSEcCtD
Dicyclomine—Diplopia—Carmustine—malignant glioma	0.0134	0.0172	CcSEcCtD
Dicyclomine—Diplopia—Temozolomide—malignant glioma	0.0129	0.0166	CcSEcCtD
Dicyclomine—Face oedema—Carmustine—malignant glioma	0.0129	0.0166	CcSEcCtD
Dicyclomine—Affect lability—Temozolomide—malignant glioma	0.0127	0.0164	CcSEcCtD
Dicyclomine—Face oedema—Temozolomide—malignant glioma	0.0125	0.0161	CcSEcCtD
Dicyclomine—Mood swings—Temozolomide—malignant glioma	0.0122	0.0158	CcSEcCtD
Dicyclomine—Muscular weakness—Carmustine—malignant glioma	0.0118	0.0152	CcSEcCtD
Dicyclomine—Breast disorder—Temozolomide—malignant glioma	0.0117	0.015	CcSEcCtD
Dicyclomine—Muscular weakness—Temozolomide—malignant glioma	0.0114	0.0147	CcSEcCtD
Dicyclomine—Abdominal distension—Temozolomide—malignant glioma	0.0112	0.0145	CcSEcCtD
Dicyclomine—Erectile dysfunction—Temozolomide—malignant glioma	0.0103	0.0132	CcSEcCtD
Dicyclomine—Hallucination—Carmustine—malignant glioma	0.0092	0.0118	CcSEcCtD
Dicyclomine—Hypoaesthesia—Carmustine—malignant glioma	0.0092	0.0118	CcSEcCtD
Dicyclomine—Hypoaesthesia—Temozolomide—malignant glioma	0.00889	0.0114	CcSEcCtD
Dicyclomine—Hallucination—Temozolomide—malignant glioma	0.00889	0.0114	CcSEcCtD
Dicyclomine—Eye disorder—Carmustine—malignant glioma	0.00864	0.0111	CcSEcCtD
Dicyclomine—Eye disorder—Temozolomide—malignant glioma	0.00835	0.0108	CcSEcCtD
Dicyclomine—Cardiac disorder—Temozolomide—malignant glioma	0.00829	0.0107	CcSEcCtD
Dicyclomine—Mental disorder—Carmustine—malignant glioma	0.0081	0.0104	CcSEcCtD
Dicyclomine—Immune system disorder—Temozolomide—malignant glioma	0.00807	0.0104	CcSEcCtD
Dicyclomine—Mediastinal disorder—Temozolomide—malignant glioma	0.00805	0.0104	CcSEcCtD
Dicyclomine—Erythema—Carmustine—malignant glioma	0.00805	0.0104	CcSEcCtD
Dicyclomine—Mental disorder—Temozolomide—malignant glioma	0.00783	0.0101	CcSEcCtD
Dicyclomine—Erythema—Temozolomide—malignant glioma	0.00778	0.01	CcSEcCtD
Dicyclomine—Vision blurred—Carmustine—malignant glioma	0.00759	0.00977	CcSEcCtD
Dicyclomine—Agitation—Carmustine—malignant glioma	0.0074	0.00952	CcSEcCtD
Dicyclomine—Vision blurred—Temozolomide—malignant glioma	0.00733	0.00944	CcSEcCtD
Dicyclomine—Ill-defined disorder—Temozolomide—malignant glioma	0.00722	0.00929	CcSEcCtD
Dicyclomine—Agitation—Temozolomide—malignant glioma	0.00715	0.0092	CcSEcCtD
Dicyclomine—Angioedema—Temozolomide—malignant glioma	0.00711	0.00915	CcSEcCtD
Dicyclomine—Malaise—Temozolomide—malignant glioma	0.00702	0.00903	CcSEcCtD
Dicyclomine—Hypertension—Carmustine—malignant glioma	0.00695	0.00895	CcSEcCtD
Dicyclomine—Palpitations—Temozolomide—malignant glioma	0.00687	0.00885	CcSEcCtD
Dicyclomine—Hypertension—Temozolomide—malignant glioma	0.00672	0.00865	CcSEcCtD
Dicyclomine—Confusional state—Carmustine—malignant glioma	0.00662	0.00853	CcSEcCtD
Dicyclomine—Oedema—Carmustine—malignant glioma	0.00657	0.00846	CcSEcCtD
Dicyclomine—Discomfort—Temozolomide—malignant glioma	0.00654	0.00842	CcSEcCtD
Dicyclomine—Dry mouth—Temozolomide—malignant glioma	0.00648	0.00834	CcSEcCtD
Dicyclomine—Tachycardia—Carmustine—malignant glioma	0.00641	0.00825	CcSEcCtD
Dicyclomine—Confusional state—Temozolomide—malignant glioma	0.0064	0.00824	CcSEcCtD
Dicyclomine—Anaphylactic shock—Temozolomide—malignant glioma	0.00635	0.00817	CcSEcCtD
Dicyclomine—Oedema—Temozolomide—malignant glioma	0.00635	0.00817	CcSEcCtD
Dicyclomine—Anorexia—Carmustine—malignant glioma	0.00626	0.00806	CcSEcCtD
Dicyclomine—Nervous system disorder—Temozolomide—malignant glioma	0.00623	0.00802	CcSEcCtD
Dicyclomine—Anorexia—Temozolomide—malignant glioma	0.00605	0.00779	CcSEcCtD
Dicyclomine—Insomnia—Carmustine—malignant glioma	0.00594	0.00765	CcSEcCtD
Dicyclomine—Paraesthesia—Carmustine—malignant glioma	0.0059	0.00759	CcSEcCtD
Dicyclomine—Dyspnoea—Carmustine—malignant glioma	0.00586	0.00754	CcSEcCtD
Dicyclomine—Somnolence—Carmustine—malignant glioma	0.00584	0.00752	CcSEcCtD
Dicyclomine—Insomnia—Temozolomide—malignant glioma	0.00574	0.00739	CcSEcCtD
Dicyclomine—Decreased appetite—Carmustine—malignant glioma	0.00571	0.00735	CcSEcCtD
Dicyclomine—Paraesthesia—Temozolomide—malignant glioma	0.0057	0.00734	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00567	0.0073	CcSEcCtD
Dicyclomine—Dyspnoea—Temozolomide—malignant glioma	0.00566	0.00729	CcSEcCtD
Dicyclomine—Somnolence—Temozolomide—malignant glioma	0.00564	0.00727	CcSEcCtD
Dicyclomine—Pain—Carmustine—malignant glioma	0.00562	0.00723	CcSEcCtD
Dicyclomine—Constipation—Carmustine—malignant glioma	0.00562	0.00723	CcSEcCtD
Dicyclomine—Dyspepsia—Temozolomide—malignant glioma	0.00559	0.00719	CcSEcCtD
Dicyclomine—Decreased appetite—Temozolomide—malignant glioma	0.00552	0.00711	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00548	0.00706	CcSEcCtD
Dicyclomine—Fatigue—Temozolomide—malignant glioma	0.00547	0.00705	CcSEcCtD
Dicyclomine—Pain—Temozolomide—malignant glioma	0.00543	0.00699	CcSEcCtD
Dicyclomine—Constipation—Temozolomide—malignant glioma	0.00543	0.00699	CcSEcCtD
Dicyclomine—Feeling abnormal—Carmustine—malignant glioma	0.00541	0.00697	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Carmustine—malignant glioma	0.00537	0.00692	CcSEcCtD
Dicyclomine—Feeling abnormal—Temozolomide—malignant glioma	0.00523	0.00674	CcSEcCtD
Dicyclomine—Abdominal pain—Carmustine—malignant glioma	0.00519	0.00669	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00519	0.00668	CcSEcCtD
Dicyclomine—Urticaria—Temozolomide—malignant glioma	0.00504	0.00649	CcSEcCtD
Dicyclomine—Abdominal pain—Temozolomide—malignant glioma	0.00502	0.00646	CcSEcCtD
Dicyclomine—Hypersensitivity—Carmustine—malignant glioma	0.00484	0.00623	CcSEcCtD
Dicyclomine—Asthenia—Carmustine—malignant glioma	0.00471	0.00607	CcSEcCtD
Dicyclomine—Hypersensitivity—Temozolomide—malignant glioma	0.00468	0.00602	CcSEcCtD
Dicyclomine—Asthenia—Temozolomide—malignant glioma	0.00456	0.00586	CcSEcCtD
Dicyclomine—Pruritus—Temozolomide—malignant glioma	0.00449	0.00578	CcSEcCtD
Dicyclomine—Dizziness—Carmustine—malignant glioma	0.00434	0.00559	CcSEcCtD
Dicyclomine—Dizziness—Temozolomide—malignant glioma	0.0042	0.0054	CcSEcCtD
Dicyclomine—Vomiting—Carmustine—malignant glioma	0.00418	0.00538	CcSEcCtD
Dicyclomine—Rash—Carmustine—malignant glioma	0.00414	0.00533	CcSEcCtD
Dicyclomine—Dermatitis—Carmustine—malignant glioma	0.00414	0.00533	CcSEcCtD
Dicyclomine—Headache—Carmustine—malignant glioma	0.00412	0.0053	CcSEcCtD
Dicyclomine—Vomiting—Temozolomide—malignant glioma	0.00404	0.0052	CcSEcCtD
Dicyclomine—Rash—Temozolomide—malignant glioma	0.004	0.00515	CcSEcCtD
Dicyclomine—Dermatitis—Temozolomide—malignant glioma	0.004	0.00515	CcSEcCtD
Dicyclomine—Headache—Temozolomide—malignant glioma	0.00398	0.00512	CcSEcCtD
Dicyclomine—Nausea—Carmustine—malignant glioma	0.0039	0.00502	CcSEcCtD
Dicyclomine—Nausea—Temozolomide—malignant glioma	0.00377	0.00485	CcSEcCtD
Dicyclomine—CHRM1—Signaling Pathways—DUSP6—malignant glioma	0.000127	0.000567	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000126	0.000566	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—DUSP6—malignant glioma	0.000126	0.000565	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—YWHAE—malignant glioma	0.000126	0.000565	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NTRK2—malignant glioma	0.000126	0.000565	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000126	0.000564	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CG—malignant glioma	0.000126	0.000563	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FLT1—malignant glioma	0.000126	0.000562	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—JAG1—malignant glioma	0.000125	0.00056	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—DUSP6—malignant glioma	0.000125	0.00056	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—JAG1—malignant glioma	0.000125	0.000558	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH3—malignant glioma	0.000124	0.000558	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CG—malignant glioma	0.000124	0.000557	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH3—malignant glioma	0.000124	0.000556	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—JAG1—malignant glioma	0.000123	0.000553	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH3—malignant glioma	0.000123	0.00055	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FBXW7—malignant glioma	0.000122	0.000549	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FBXW7—malignant glioma	0.000122	0.000547	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FBXW7—malignant glioma	0.000121	0.000542	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BDKRB2—malignant glioma	0.00012	0.000538	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BDKRB2—malignant glioma	0.00012	0.000536	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—F2—malignant glioma	0.00012	0.000536	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—F2—malignant glioma	0.000119	0.000534	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BDKRB2—malignant glioma	0.000119	0.000531	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GSTP1—malignant glioma	0.000118	0.000529	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—F2—malignant glioma	0.000118	0.000529	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—BCHE—malignant glioma	0.000118	0.000528	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—SLC5A5—malignant glioma	0.000116	0.000522	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT2—malignant glioma	0.000115	0.000516	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT2—malignant glioma	0.000115	0.000515	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAT—malignant glioma	0.000115	0.000515	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CG—malignant glioma	0.000114	0.000512	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CG—malignant glioma	0.000114	0.000511	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT2—malignant glioma	0.000114	0.00051	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CG—malignant glioma	0.000113	0.000506	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PTPN11—malignant glioma	0.000112	0.000504	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PTPN11—malignant glioma	0.000112	0.000502	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH2—malignant glioma	0.000112	0.0005	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH2—malignant glioma	0.000111	0.000499	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PTPN11—malignant glioma	0.000111	0.000497	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000111	0.000496	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CD—malignant glioma	0.00011	0.000495	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH2—malignant glioma	0.00011	0.000494	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00011	0.000493	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CD—malignant glioma	0.000109	0.00049	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KNG1—malignant glioma	0.000109	0.000489	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000109	0.000489	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KNG1—malignant glioma	0.000109	0.000488	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NCOR1—malignant glioma	0.000108	0.000486	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KNG1—malignant glioma	0.000108	0.000483	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT2—malignant glioma	0.000105	0.000469	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT2—malignant glioma	0.000104	0.000467	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NTRK1—malignant glioma	0.000104	0.000466	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NTRK1—malignant glioma	0.000104	0.000465	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT2—malignant glioma	0.000103	0.000463	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NTRK1—malignant glioma	0.000103	0.00046	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CD—malignant glioma	0.000101	0.000451	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CD—malignant glioma	0.0001	0.000449	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	9.93e-05	0.000445	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP3—malignant glioma	9.68e-05	0.000434	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CB—malignant glioma	9.65e-05	0.000432	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP3—malignant glioma	9.65e-05	0.000432	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CB—malignant glioma	9.62e-05	0.000431	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	9.6e-05	0.00043	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CDKN2B—malignant glioma	9.56e-05	0.000428	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP3—malignant glioma	9.56e-05	0.000428	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	9.53e-05	0.000427	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.52e-05	0.000426	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	9.47e-05	0.000424	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GSTP1—malignant glioma	9.38e-05	0.00042	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTK2—malignant glioma	9.32e-05	0.000417	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTK2—malignant glioma	9.29e-05	0.000416	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	9.28e-05	0.000416	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	9.25e-05	0.000414	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTK2—malignant glioma	9.2e-05	0.000412	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	9.16e-05	0.00041	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HES1—malignant glioma	9.15e-05	0.00041	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAT—malignant glioma	9.13e-05	0.000409	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HES1—malignant glioma	9.12e-05	0.000409	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NCOR1—malignant glioma	9.1e-05	0.000408	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NCOR1—malignant glioma	9.07e-05	0.000406	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HES1—malignant glioma	9.04e-05	0.000405	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NCOR1—malignant glioma	8.98e-05	0.000402	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—RAF1—malignant glioma	8.98e-05	0.000402	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—RAF1—malignant glioma	8.95e-05	0.000401	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—IL2—malignant glioma	8.86e-05	0.000397	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—RAF1—malignant glioma	8.86e-05	0.000397	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAV1—malignant glioma	8.84e-05	0.000396	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—IL2—malignant glioma	8.84e-05	0.000396	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	8.77e-05	0.000393	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—IL2—malignant glioma	8.75e-05	0.000392	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	8.74e-05	0.000391	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	8.72e-05	0.00039	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	8.69e-05	0.000389	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	8.65e-05	0.000388	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NCOR1—malignant glioma	8.62e-05	0.000386	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	8.6e-05	0.000385	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SPP1—malignant glioma	8.46e-05	0.000379	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SPP1—malignant glioma	8.43e-05	0.000378	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	8.42e-05	0.000377	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	8.4e-05	0.000376	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SPP1—malignant glioma	8.35e-05	0.000374	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	8.32e-05	0.000373	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CG—malignant glioma	8.06e-05	0.000361	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL2—malignant glioma	8.05e-05	0.000361	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL2—malignant glioma	8.02e-05	0.00036	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TERT—malignant glioma	8.02e-05	0.000359	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TERT—malignant glioma	8e-05	0.000358	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL2—malignant glioma	7.95e-05	0.000356	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TERT—malignant glioma	7.92e-05	0.000355	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PDGFB—malignant glioma	7.83e-05	0.000351	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PDGFB—malignant glioma	7.8e-05	0.00035	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGFR1—malignant glioma	7.79e-05	0.000349	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—malignant glioma	7.78e-05	0.000348	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGFR1—malignant glioma	7.76e-05	0.000348	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	7.73e-05	0.000346	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	7.69e-05	0.000344	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HIF1A—malignant glioma	7.67e-05	0.000344	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HIF1A—malignant glioma	7.65e-05	0.000343	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	7.57e-05	0.000339	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CAV1—malignant glioma	7.42e-05	0.000332	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CAV1—malignant glioma	7.4e-05	0.000331	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KDR—malignant glioma	7.34e-05	0.000329	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CAV1—malignant glioma	7.32e-05	0.000328	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KDR—malignant glioma	7.31e-05	0.000328	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KDR—malignant glioma	7.24e-05	0.000324	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CD—malignant glioma	7.08e-05	0.000317	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FN1—malignant glioma	7.06e-05	0.000316	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—F2—malignant glioma	7.06e-05	0.000316	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—F2—malignant glioma	7.04e-05	0.000315	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FN1—malignant glioma	7.04e-05	0.000315	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAV1—malignant glioma	7.03e-05	0.000315	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BAD—malignant glioma	6.98e-05	0.000313	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—F2—malignant glioma	6.97e-05	0.000312	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FN1—malignant glioma	6.97e-05	0.000312	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BAD—malignant glioma	6.96e-05	0.000312	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	6.91e-05	0.00031	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	6.89e-05	0.000309	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BAD—malignant glioma	6.89e-05	0.000309	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	6.82e-05	0.000306	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CD80—malignant glioma	6.77e-05	0.000303	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APC—malignant glioma	6.76e-05	0.000303	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	6.76e-05	0.000303	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CD80—malignant glioma	6.75e-05	0.000302	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APC—malignant glioma	6.74e-05	0.000302	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	6.74e-05	0.000302	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.71e-05	0.000301	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CD80—malignant glioma	6.68e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EGF—malignant glioma	6.68e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APC—malignant glioma	6.67e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	6.67e-05	0.000299	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EGF—malignant glioma	6.66e-05	0.000298	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTPN11—malignant glioma	6.64e-05	0.000297	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTPN11—malignant glioma	6.62e-05	0.000296	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EGF—malignant glioma	6.59e-05	0.000295	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	6.55e-05	0.000294	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CG—malignant glioma	6.4e-05	0.000287	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BRAF—malignant glioma	6.35e-05	0.000285	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BRAF—malignant glioma	6.33e-05	0.000284	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BRAF—malignant glioma	6.27e-05	0.000281	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT2—malignant glioma	6.18e-05	0.000277	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—malignant glioma	6.18e-05	0.000277	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CB—malignant glioma	6.17e-05	0.000277	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT2—malignant glioma	6.16e-05	0.000276	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—EGFR—malignant glioma	6.16e-05	0.000276	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—EGFR—malignant glioma	6.14e-05	0.000275	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—malignant glioma	6.12e-05	0.000274	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT2—malignant glioma	6.1e-05	0.000273	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	6.08e-05	0.000272	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	5.94e-05	0.000266	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	5.92e-05	0.000265	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	5.88e-05	0.000264	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	5.87e-05	0.000263	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	5.86e-05	0.000263	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—KRAS—malignant glioma	5.82e-05	0.000261	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	5.81e-05	0.00026	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—KRAS—malignant glioma	5.8e-05	0.00026	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	5.74e-05	0.000257	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FGF2—malignant glioma	5.69e-05	0.000255	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FGF2—malignant glioma	5.67e-05	0.000254	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CD—malignant glioma	5.63e-05	0.000252	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FGF2—malignant glioma	5.62e-05	0.000252	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	5.34e-05	0.000239	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTEN—malignant glioma	5.33e-05	0.000239	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	5.33e-05	0.000239	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MDM2—malignant glioma	5.32e-05	0.000238	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MDM2—malignant glioma	5.31e-05	0.000238	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RAF1—malignant glioma	5.3e-05	0.000238	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RAF1—malignant glioma	5.29e-05	0.000237	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	5.27e-05	0.000236	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MDM2—malignant glioma	5.25e-05	0.000235	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	5.25e-05	0.000235	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RAF1—malignant glioma	5.24e-05	0.000235	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ERBB2—malignant glioma	5.23e-05	0.000234	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	5.18e-05	0.000232	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	5.18e-05	0.000232	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	5.16e-05	0.000231	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	5.11e-05	0.000229	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	4.98e-05	0.000223	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	4.96e-05	0.000222	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	4.91e-05	0.00022	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CB—malignant glioma	4.9e-05	0.00022	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—malignant glioma	4.86e-05	0.000218	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	4.81e-05	0.000215	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	4.79e-05	0.000215	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CASP3—malignant glioma	4.76e-05	0.000213	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL2—malignant glioma	4.76e-05	0.000213	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CASP3—malignant glioma	4.75e-05	0.000213	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	4.75e-05	0.000213	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL2—malignant glioma	4.74e-05	0.000212	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CASP3—malignant glioma	4.7e-05	0.000211	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL2—malignant glioma	4.69e-05	0.00021	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—malignant glioma	4.5e-05	0.000202	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—malignant glioma	4.49e-05	0.000201	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PTEN—malignant glioma	4.47e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PTEN—malignant glioma	4.46e-05	0.0002	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—malignant glioma	4.44e-05	0.000199	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PTEN—malignant glioma	4.42e-05	0.000198	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	4.37e-05	0.000196	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	4.35e-05	0.000195	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	4.31e-05	0.000193	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTEN—malignant glioma	4.24e-05	0.00019	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	4.04e-05	0.000181	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	4.03e-05	0.00018	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—STAT3—malignant glioma	4e-05	0.000179	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.99e-05	0.000179	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STAT3—malignant glioma	3.99e-05	0.000179	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STAT3—malignant glioma	3.95e-05	0.000177	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CA—malignant glioma	3.76e-05	0.000169	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MYC—malignant glioma	3.72e-05	0.000167	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MYC—malignant glioma	3.71e-05	0.000166	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MYC—malignant glioma	3.67e-05	0.000164	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—EGFR—malignant glioma	3.64e-05	0.000163	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—EGFR—malignant glioma	3.63e-05	0.000162	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.59e-05	0.000161	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—KRAS—malignant glioma	3.44e-05	0.000154	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—KRAS—malignant glioma	3.42e-05	0.000153	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.39e-05	0.000152	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	3.16e-05	0.000141	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	3.15e-05	0.000141	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	3.12e-05	0.00014	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—malignant glioma	3.07e-05	0.000138	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TP53—malignant glioma	3.05e-05	0.000137	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TP53—malignant glioma	3.04e-05	0.000136	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TP53—malignant glioma	3.01e-05	0.000135	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.99e-05	0.000134	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—malignant glioma	2.58e-05	0.000116	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—malignant glioma	2.57e-05	0.000115	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.55e-05	0.000114	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—malignant glioma	2.44e-05	0.000109	CbGpPWpGaD
